BACKGROUND Human menopausal gonadotropin (hMG) has contributed many improvements to human assisted reproduction. However, effects of hMG on oocyte development and clinical results remain controversial. OBJECTIVE This study was conducted to investigate the effects of hMG on the zona pellucida of oocytes, as well as clinical results in superovulation treatment. MATERIALS AND METHODS This retr...

background: human menopausal gonadotropin (hmg) has contributed many improvements to human assisted reproduction. however, effects of hmg on oocyte development and clinical results remain controversial. objective: this study was conducted to investigate the effects of hmg on the zona pellucida of oocytes, as well as clinical results in superovulation treatment. materials and methods: this retro...

BACKGROUND This study compared rates of pregnancy and in vitro fertilization (IVF) parameters in subjects stimulated with follicle stimulating hormone (FSH) plus either recombinant human luteinizing hormone (r-LH) or human menopausal gonadotropin (hMG) in a long gonadotropin releasing hormone (GnRH) agonist IVF protocol. MATERIALS AND METHODS This cohort study enrolled patients who underwent ...

Objective The objective of this study is to compare rates of pregnancy and IVF parameters in subjects who were stimulated with follicle stimulating hormone (FSH) plus either recombinant human luteinizing hormone (r-LH) or human menopausal gonadotropins (hMG), in long gonadotropin releasing hormone (GnRH) agonist IVF protocols. MaterialsAndMethods This is a cohort study of patients undergoing IV...

objective: the objective of this study is to compare rates of pregnancy and ivf parameters in subjects who were stimulated with follicle stimulating hormone (fsh) plus either recombinant human luteinizing hormone (r-lh) or human menopausal gonadotropins (hmg), in long gonadotropin releasing hormone (gnrh) agonist ivf protocols. materials and methods: this is a cohort study of patients undergoin...

Aim: The aim of this case-control study was to compare the efficacy of highly purified human menopausal gonadotropin (HPhMG) vs recombinant follicle stimulating hormone (r-FSH) treatments following GnRH agonist suppression in patients undergoing intracytoplasmic sperm injection (ICSI) with moderate male factor infertility in terms of oocyte and embryo quality and clinical pregnancy outcomes. Ma...